Pharmaceutical Package Labeling Artwork Project Coordinator
ZoetisFull Time
Mid-level (3 to 4 years)
Candidates must have experience in regulatory affairs global labeling, providing strategic input and oversight for complex products, primarily within virology and/or inflammation therapeutic areas. They should be able to develop labeling strategies, lead Core Labeling Working Group, Target Product Label, and U.S. Product Information team meetings, and represent RA Labeling across organizational levels. Experience managing complex labeling negotiations with regulatory authorities and acting as a central contact and expert for global Regulatory teams in interpreting Company Core Data Sheets (CCDSs) and USPIs is required. The role may involve managing, overseeing, reviewing, and approving the work of junior staff, and potentially serving as a member of the RA Labeling Leadership Team.
The Director, Regulatory Affairs - Global Labeling will be responsible for creating, updating, and maintaining product information and labeling documentation for all relevant Gilead products to ensure compliance with governing laws, regulations, and company policies. They will lead the development of labeling strategies for multiple products, manage labeling negotiations with regulatory authorities, and advise cross-functional partners on labeling matters. Responsibilities include leading impact assessments on major global labeling issues, preparing and submitting USPIs as part of BLAs, sBLAs, NDAs, or sNDAs, and assisting with governance and decision-making meetings related to regulatory labeling. The role also involves leading initiatives to improve Regulatory Affairs capabilities and potentially training cross-functional partners on labeling processes and policies.
Develops and commercializes biopharmaceuticals
Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.